The finalized rule is another step in the right direction for pharmacies calling for reform due to underwater reimbursement and other PBM pressures.
|Slideshows|June 9, 2023
Boost Summertime Sales With These Front-End Items
Author(s)Lauren Biscaldi, MS
Stock solutions to common summer maladies in the pharmacy's front end.
Advertisement
From the beach to the mountains, the summer months offer a wide variety of outdoor activities. The downside to this increased time spent outside is an increase in individuals experiencing conditions like allergies, sunburn, scrapes, and bruises. Through smart use of front-end space, pharmacists can turn their stores into a one-stop shop for patients looking to address some of the most common summer conditions.
References
Ducharme J. Why allergy seasons are getting worse. TIME. May 9, 2023. Accessed June 8, 2023.
https://time.com/6278183/allergy-season-worse-health-impact/ Which allergy medicine works best? Cleveland Clinic. June 14, 2022. Accessed June 8, 2023.
https://health.clevelandclinic.org/best-otc-allergy-medicine/ Key statistics for melanoma skin cancer. American Cancer Society. Updated January 12, 2023. Accessed June 8, 2023.
https://www.cancer.org/cancer/types/melanoma-skin-cancer/about/key-statistics.html Living Better newsletter. Piedmont Healthcare. Accessed June 8, 2023.
https://www.piedmont.org/living-better/what-are-sunglasses-really-doing-for-your-eyes
Advertisement
Related to this article
Allison Schneider, MPH, provides a detailed update regarding pharmacies’ impact within Medicare price negotiations and the legislation further impacting businesses.
This episode breaks down how PBMs conduct inventory audits, the sourcing and timing issues that trigger recoupments, and how pharmacies can prepare and push back.
In part 2, Allison Schneider, MPH, discusses PBM and 340B reform that could compound pharmacies’ burden amid ongoing Medicare drug price negotiations.
Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to come in the years ahead.
AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.
Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Advertisement
Advertisement
Trending on Drug Topics
1
Updated Diabetes Consensus Shifts Focus from Glucose Control to Whole-Person Care
2
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
3
COVID-19, Flu Shots Coadministered Are Well-Tolerated in Pregnancy
4
Pharmacies Face Persistent MFP Cash Crunch Amid PBM, 340B Shifts
5